Annual report pursuant to Section 13 and 15(d)

Statements of Cash Flows

v3.22.1
Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (526) $ (2,632,760)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of warrants   (956,035)
Interest earned on cash and marketable securities held in Trust Account   (115,444)
Changes in operating assets and liabilities:    
Prepaid expenses   (279,666)
Accrued offering costs and expense 500 3,311,387
Due to related party   214
Net cash used in operating activities (26) (672,304)
Cash flows from investing activities:    
Investment held in Trust Account   (276,000,000)
Net cash used in investing activities   (276,000,000)
Cash flows from financing activities:    
Proceeds from Initial Public Offering, net of underwriters’ fees   270,480,000
Proceeds from private placement   7,270,000
Payments of offering costs   (651,036)
Proceeds from issuance of promissory note to related party 175,000 150,000
Payment of promissory note to related party (25,000) (150,000)
Payment of deferred offering costs (114,360) (14,849,933)
Net cash provided by financing activities 35,640 277,098,964
Net change in cash 35,614 426,660
Cash, beginning of the period   35,614
Cash, end of the period 35,614 462,274
Supplemental disclosure of noncash investing and financing activities:    
Deferred underwriting commissions charged to additional paid-in capital   9,660,000
Initial value of common stock subject to possible redemption   276,000,000
Deferred offering costs paid by Sponsor loan   18,773
Modification to Private Placement Warrants to qualify as liability   $ 6,000,476
Deferred offering costs included in accrued expenses 329,800  
Deferred offering costs paid by Sponsor in exchange for issuance of Common Stock $ 25,000